Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -8.99
- Piotroski Score 6.00
- Grade N/A
- Symbol (SXTP)
- Company 60 Degrees Pharmaceuticals, Inc.
- Price $0.87
- Changes Percentage (-1.15%)
- Change -$0.01
- Day Low $0.86
- Day High $0.94
- Year High $18.36
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/18/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.06
- Trailing P/E Ratio -5.85
- Forward P/E Ratio -5.85
- P/E Growth -5.85
- Net Income $-3,765,702
Income Statement
Quarterly
Annual
Latest News of SXTP
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now?
The article discusses the current market situation amid fears of a US recession, with a focus on the performance of 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and its potential as a new penny stoc...
By Yahoo! Finance | 3 months ago
